GB955891A - Stable preparations of prednisone derivatives and process for the manufacture thereof - Google Patents

Stable preparations of prednisone derivatives and process for the manufacture thereof

Info

Publication number
GB955891A
GB955891A GB2264/62A GB226462A GB955891A GB 955891 A GB955891 A GB 955891A GB 2264/62 A GB2264/62 A GB 2264/62A GB 226462 A GB226462 A GB 226462A GB 955891 A GB955891 A GB 955891A
Authority
GB
United Kingdom
Prior art keywords
oil
water
manufacture
ethyl
aliphatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2264/62A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Laboratories Ltd
Original Assignee
Organon Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Laboratories Ltd filed Critical Organon Laboratories Ltd
Publication of GB955891A publication Critical patent/GB955891A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB2264/62A 1961-01-31 1962-01-22 Stable preparations of prednisone derivatives and process for the manufacture thereof Expired GB955891A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL260648 1961-01-31

Publications (1)

Publication Number Publication Date
GB955891A true GB955891A (en) 1964-04-22

Family

ID=19752844

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2264/62A Expired GB955891A (en) 1961-01-31 1962-01-22 Stable preparations of prednisone derivatives and process for the manufacture thereof

Country Status (3)

Country Link
FR (1) FR2115M (enExample)
GB (1) GB955891A (enExample)
NL (2) NL260648A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ297632B6 (cs) * 1996-12-09 2007-02-14 Pharmacia & Upjohn Company Zlepsené farmaceutické kompozice

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ297632B6 (cs) * 1996-12-09 2007-02-14 Pharmacia & Upjohn Company Zlepsené farmaceutické kompozice

Also Published As

Publication number Publication date
NL260648A (enExample)
FR2115M (fr) 1963-11-04
NL120012C (enExample)

Similar Documents

Publication Publication Date Title
Loewe Studies on the pharmacology and acute toxicity of compounds with marihuana activity
UA41502C2 (uk) Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
KR960010008A (ko) 수성 경비 현탁액
GB955891A (en) Stable preparations of prednisone derivatives and process for the manufacture thereof
CH418351A (de) Verfahren zur Herstellung von neuen 6,11-Dihydrodibenz(b,e)thiepin-Derivaten und deren Salzen
DE3852111T2 (de) Galenische Formen von Allergenen für die sublinguale Verabreichung.
DE1620629C3 (de) Verwendung eines Salzes von 2-Merkaptoäthansulf onsäure zur Herstellung von Mukolytica
KR930700088A (ko) 흡입투여를 위한 타우린-기저 약학 조성물
Greenwood et al. Preoperative medication for day-case surgery: a comparison between oxazepam and temazepam
GB907430A (en) A method for the preparation of chemically stable liquid suspensions of erythromycinand the suspensions so prepared
US3231469A (en) beta-benzalbutyramide as an anticholesterolemic agent
Scudi et al. Some Pharmacological Characteristics of Bacitracin II. Absorption and Excretion of Bacitracin in the Dog.
EP0022426B1 (de) Nasalpräparate und Verfahren zu deren Herstellung
Raventos Wound healing and mortality after total body exposure to ionizing radiation
Leake Vitamin D toxicity
Robinson Use of fludrocortisone acetate in dermatoses
DE3044753C2 (enExample)
ATE179070T1 (de) Dithranol enthaltendes arzneimittel zur topischen anwendung sowie herstellungsverfahren
Cochin et al. Further Observations on Addiction to Methadon in the Monkey.
Ryrie Pregnancy and leprosy
Leeson et al. Steroid borates II. Process applications
LEMERE New steroid hormone tranquilizing agent (Cetadiol)
MILZOFF CARDIOVASCULAR PHARMACOLOGY OF DELTA (9)-TETRAHYDROCANNABINOL
DE1617438C3 (de) Verfahren zur Herstellung von Lösungen basisch-reagierender Arzneistoffe
DE2542225A1 (de) Antiallergische pharmazeutische zubereitungen